Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
58 /100
HIGH RISK
Score updated Aug 28, 2026

IRD — Opus Genetics, Inc. Dilution Risk Tracker

Track IRD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IRD — Get alerts when the score changes →

As of August 28, 2026, Opus Genetics, Inc. (IRD) has a DilutionWatch DilutionScore of 58/100, rated HIGH dilution risk. Opus Genetics, Inc. has a market capitalization of $354.88M, 83.20M shares outstanding, 79 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $25.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
10
📊 Float Risk
55
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 14%
💰 Capital Raise model 20%
• Active shelf registration ($25M, 7% of market cap)
🔄 Reverse Split model est. 15%
• 52-week low $0.90 has breached $1
🔔 Track IRD — Get forecast alerts →

Market Data

Market Cap$354.88M
Shares Outstanding83.20M
Float34.48M
Cash$88.81M
Debt$1.20M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 87.4% shares (2026Q1 vs prior)
79 institutional holders · 52.36M shares
#1 Caligan Partners LP 6.08M shares
#2 ADAGE CAPITAL PARTNERS GP, L.L.C. 6.03M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 4.90M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest10.85M
Days to Cover11.9
% of Float31.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
xbrl XBRL WARRANT 2025-12-31
Form 4 INSIDER TRANSACTION 2026-07-23
Form 4 INSIDER TRANSACTION 2026-07-23
Form 4 INSIDER TRANSACTION 2026-07-23
Full SEC filing analysis available with free account

Recent News

No recent news

Factual IRD Dilution Snapshot

Opus Genetics, Inc. (IRD) has a DilutionScore of 58/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track IRD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IRD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IRD
IRD FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.